{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:17:15Z","timestamp":1780449435132,"version":"3.54.1"},"reference-count":38,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"name":"CIBERES","award":["PI14\/1296"],"award-info":[{"award-number":["PI14\/1296"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/1296"],"award-info":[{"award-number":["PI14\/1296"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2019,6,25]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>We aimed to assess the main causes of intensive care unit (ICU) readmissions in lung transplant adults and to identify independent predictors of ICU mortality (primary end-point).<\/jats:p><jats:p>This Spanish five-centre prospective cohort study enrolled all lung transplant adults with ICU readmissions after post-transplant ICU discharge between 2012 and 2016. Patients were followed until hospital discharge or death.<\/jats:p><jats:p>153 lung transplant recipients presented 174 ICU readmissions at a median (interquartile range) of 6 (2\u201325) months post-transplant. Chronic lung allograft dysfunction was reported in 39 (25.5%) recipients, 13 of whom (all exitus) had restrictive allograft syndrome (RAS). Acute respiratory failure (ARF) (110 (71.9%)) was the main condition requiring ICU readmission. Graft rejection (six (5.4%) acute) caused only 12 (10.8%) readmissions whereas pneumonia (56 (36.6%)) was the main cause (50 admitted for ARF and six for shock), with<jats:italic>Pseudomonas aeruginosa<\/jats:italic>(50% multidrug resistant) being the predominant pathogen. 55 (35.9%) and 69 (45.1%) recipients died in the ICU and the hospital, respectively. Bronchiolitis obliterans syndrome (BOS) stage 2 (adjusted OR (aOR) 7.2 (95% CI 1.0\u201365.7)), BOS stage 3 (aOR 13.7 (95% CI 2.5\u201395.3)), RAS (aOR &gt;50) and pneumonia at ICU readmission (aOR 2.5 (95% CI 1.0\u20137.1)) were identified in multivariate analyses as independent predictors of ICU mortality. Only eight (5.2%) patients had positive donor-specific antibodies prior to ICU readmission and this variable did not affect the model.<\/jats:p><jats:p>ARF was the main condition requiring ICU readmission in lung transplant recipients and was associated with high mortality. Pneumonia was the main cause of death and was also an independent predictor. RAS should receive palliative care rather than ICU admission.<\/jats:p>","DOI":"10.1183\/13993003.01512-2018","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T12:25:21Z","timestamp":1564057521000},"page":"1801512","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Pneumonia<i>versus<\/i>graft dysfunction as the cause of acute respiratory failure after lung transplant: a 4-year multicentre prospective study in 153 adults requiring intensive care admission"],"prefix":"10.1183","volume":"54","author":[{"given":"Cristopher","family":"Mazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-1189","authenticated-orcid":false,"given":"Teresa","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edsa","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzdivina","family":"Rell\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"2024102101030988000_54.3.1801512.1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart\u2013Lung Transplant Report 2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Yusen","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102101030988000_54.3.1801512.2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.medin.2012.03.009","article-title":"Lung transplant: an emerging challenge in the ICU","volume":"36","author":"Rello","year":"2012","journal-title":"Med Intensiva"},{"key":"2024102101030988000_54.3.1801512.3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCC.0b013e328356d982","article-title":"The lung transplant patient in the ICU","volume":"18","author":"Fuehner","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"2024102101030988000_54.3.1801512.4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pupt.2014.07.003","article-title":"Therapeutic approach to respiratory infections in lung transplantation","volume":"32","author":"Clajus","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"2024102101030988000_54.3.1801512.5","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12209"},{"key":"2024102101030988000_54.3.1801512.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2015.08.014"},{"key":"2024102101030988000_54.3.1801512.7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.arbres.2016.12.019","article-title":"Risk factors for mortality in 272 patients with lung transplant: a multicenter analysis of 7 intensive care units","volume":"53","author":"Rello","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"2024102101030988000_54.3.1801512.8","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12579"},{"key":"2024102101030988000_54.3.1801512.9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40472-016-0112-y","article-title":"Update on chronic lung allograft dysfunction","volume":"3","author":"Gauthier","year":"2016","journal-title":"Curr Transplant Rep"},{"key":"2024102101030988000_54.3.1801512.10","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"2024102101030988000_54.3.1801512.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02558.x"},{"key":"2024102101030988000_54.3.1801512.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.504"},{"key":"2024102101030988000_54.3.1801512.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.06.058"},{"key":"2024102101030988000_54.3.1801512.14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.healun.2010.08.016","article-title":"Outcome of lung transplant recipients requiring readmission to the intensive care unit","volume":"30","author":"Cohen","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2024102101030988000_54.3.1801512.15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.3.1040"},{"key":"2024102101030988000_54.3.1801512.16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1378\/chest.14-0191","article-title":"Characteristics and outcomes of patients with lung transplantation requiring admission to the medical ICU","volume":"146","author":"Banga","year":"2014","journal-title":"Chest"},{"key":"2024102101030988000_54.3.1801512.17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.4.1056"},{"key":"2024102101030988000_54.3.1801512.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200405-644ST"},{"key":"2024102101030988000_54.3.1801512.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.10.017"},{"key":"2024102101030988000_54.3.1801512.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2012.11.005"},{"key":"2024102101030988000_54.3.1801512.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000050454.01978.3B"},{"key":"2024102101030988000_54.3.1801512.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2004.11.049"},{"key":"2024102101030988000_54.3.1801512.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.08.004"},{"key":"2024102101030988000_54.3.1801512.24","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2016. Breakpoint tables for interpretation of MICs and zone diameters, versions 1.3 and 2.0. www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents Date last accessed: July 10, 2019."},{"key":"2024102101030988000_54.3.1801512.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"2024102101030988000_54.3.1801512.26","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872"},{"key":"2024102101030988000_54.3.1801512.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00365.x"},{"key":"2024102101030988000_54.3.1801512.28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s10096-017-3039-z","article-title":"The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs","volume":"36","author":"Borgatta","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024102101030988000_54.3.1801512.29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.transproceed.2008.03.118","article-title":"Sepsis in transplanted patients: beyond antibiotic therapy","volume":"40","author":"Perri","year":"2008","journal-title":"Transplant Proc"},{"key":"2024102101030988000_54.3.1801512.30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.healun.2016.04.019","article-title":"Airway complications after lung transplantation: contemporary survival and outcomes","volume":"35","author":"Awori Hayanga","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024102101030988000_54.3.1801512.31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1378\/chest.14-1948","article-title":"Understanding the concept of health care-associated pneumonia in lung transplant recipients","volume":"148","author":"Palacio","year":"2015","journal-title":"Chest"},{"key":"2024102101030988000_54.3.1801512.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00095214"},{"key":"2024102101030988000_54.3.1801512.33","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13478"},{"key":"2024102101030988000_54.3.1801512.34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcrc.2017.10.047","article-title":"Procalcitonin accurately predicts lung transplant adults with low risk of pulmonary graft dysfunction and intensive care mortality","volume":"44","author":"Mazo","year":"2018","journal-title":"J Crit Care"},{"key":"2024102101030988000_54.3.1801512.35","doi-asserted-by":"crossref","first-page":"e12811","DOI":"10.1111\/tid.12811","article-title":"DNA-based testing in lung transplant recipients with suspected non-viral lower respiratory tract infection: a prospective observational study","volume":"20","author":"Drick","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2024102101030988000_54.3.1801512.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01190-2017"},{"key":"2024102101030988000_54.3.1801512.37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/152692480701700209","article-title":"Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation","volume":"17","author":"K\u00fcnsebeck","year":"2007","journal-title":"Prog Transplant"},{"key":"2024102101030988000_54.3.1801512.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01882.x"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01512-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:41:22Z","timestamp":1740382882000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01512-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1183\/13993003.01512-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01512-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}